1 Study Coverage 1.1 Human Interleukin-2 (IL-2) Product Introduction 1.2 Market by Type 1.2.1 Global Human Interleukin-2 (IL-2) Market Size Growth Rate by Type 1.2.2 50000 U 1.2.3 100000 U 1.2.4 200000 U 1.2.5 500000 U 1.2.6 1 Million U 1.2.7 2 Million U 1.3 Market by Application 1.3.1 Global Human Interleukin-2 (IL-2) Market Size Growth Rate by Application 1.3.2 Recombinant Interferon 1.3.3 Recombinant Interleukin 1.3.4 Natural Biological Products 1.3.5 Poison Immune 1.3.6 Gene Therapy 1.3.7 Monoclonal Antibody 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Interleukin-2 (IL-2) Market Size, Estimates and Forecasts 2.1.1 Global Human Interleukin-2 (IL-2) Revenue 2016-2027 2.1.2 Global Human Interleukin-2 (IL-2) Sales 2016-2027 2.2 Global Human Interleukin-2 (IL-2), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Human Interleukin-2 (IL-2) Historical Market Size by Region (2016-2021) 2.3.1 Global Human Interleukin-2 (IL-2) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Human Interleukin-2 (IL-2) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Human Interleukin-2 (IL-2) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Human Interleukin-2 (IL-2) Sales Forecast by Region (2022-2027) 2.4.2 Global Human Interleukin-2 (IL-2) Revenue Forecast by Region (2022-2027) 3 Global Human Interleukin-2 (IL-2) Competitor Landscape by Players 3.1 Global Top Human Interleukin-2 (IL-2) Manufacturers by Sales 3.1.1 Global Human Interleukin-2 (IL-2) Sales by Manufacturer (2016-2021) 3.1.2 Global Human Interleukin-2 (IL-2) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Human Interleukin-2 (IL-2) Manufacturers by Revenue 3.2.1 Key Human Interleukin-2 (IL-2) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Human Interleukin-2 (IL-2) Revenue by Manufacturers (2016-2021) 3.2.3 Global Human Interleukin-2 (IL-2) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Human Interleukin-2 (IL-2) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Human Interleukin-2 (IL-2) Revenue in 2020 3.2.6 Global Human Interleukin-2 (IL-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Human Interleukin-2 (IL-2) Price by Manufacturers 3.4 Global Human Interleukin-2 (IL-2) Manufacturing Base Distribution, Product Types 3.4.1 Human Interleukin-2 (IL-2) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Human Interleukin-2 (IL-2) Product Type 3.4.3 Date of International Manufacturers Enter into Human Interleukin-2 (IL-2) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Human Interleukin-2 (IL-2) Market Size by Type (2016-2021) 4.1.1 Global Human Interleukin-2 (IL-2) Sales by Type (2016-2021) 4.1.2 Global Human Interleukin-2 (IL-2) Revenue by Type (2016-2021) 4.1.3 Human Interleukin-2 (IL-2) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Human Interleukin-2 (IL-2) Market Size Forecast by Type (2022-2027) 4.2.1 Global Human Interleukin-2 (IL-2) Sales Forecast by Type (2022-2027) 4.2.2 Global Human Interleukin-2 (IL-2) Revenue Forecast by Type (2022-2027) 4.2.3 Human Interleukin-2 (IL-2) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Human Interleukin-2 (IL-2) Market Size by Application (2016-2021) 5.1.1 Global Human Interleukin-2 (IL-2) Sales by Application (2016-2021) 5.1.2 Global Human Interleukin-2 (IL-2) Revenue by Application (2016-2021) 5.1.3 Human Interleukin-2 (IL-2) Price by Application (2016-2021) 5.2 Human Interleukin-2 (IL-2) Market Size Forecast by Application (2022-2027) 5.2.1 Global Human Interleukin-2 (IL-2) Sales Forecast by Application (2022-2027) 5.2.2 Global Human Interleukin-2 (IL-2) Revenue Forecast by Application (2022-2027) 5.2.3 Global Human Interleukin-2 (IL-2) Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027 6.1.1 China Human Interleukin-2 (IL-2) Sales YoY Growth 2016-2027 6.1.2 China Human Interleukin-2 (IL-2) Revenue YoY Growth 2016-2027 6.1.3 China Human Interleukin-2 (IL-2) Market Share in Global Market 2016-2027 6.2 China Human Interleukin-2 (IL-2) Market Size by Players (International and Local Players) 6.2.1 China Top Human Interleukin-2 (IL-2) Players by Sales (2016-2021) 6.2.2 China Top Human Interleukin-2 (IL-2) Players by Revenue (2016-2021) 6.3 China Human Interleukin-2 (IL-2) Historic Market Review by Type (2016-2021) 6.3.1 China Human Interleukin-2 (IL-2) Sales Market Share by Type (2016-2021) 6.3.2 China Human Interleukin-2 (IL-2) Revenue Market Share by Type (2016-2021) 6.3.3 China Human Interleukin-2 (IL-2) Price by Type (2016-2021) 6.4 China Human Interleukin-2 (IL-2) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Human Interleukin-2 (IL-2) Sales Forecast by Type (2022-2027) 6.4.2 China Human Interleukin-2 (IL-2) Revenue Forecast by Type (2022-2027) 6.4.3 China Human Interleukin-2 (IL-2) Price Forecast by Type (2022-2027) 6.5 China Human Interleukin-2 (IL-2) Historic Market Review by Application (2016-2021) 6.5.1 China Human Interleukin-2 (IL-2) Sales Market Share by Application (2016-2021) 6.5.2 China Human Interleukin-2 (IL-2) Revenue Market Share by Application (2016-2021) 6.5.3 China Human Interleukin-2 (IL-2) Price by Application (2016-2021) 6.6 China Human Interleukin-2 (IL-2) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Human Interleukin-2 (IL-2) Sales Forecast by Application (2022-2027) 6.6.2 China Human Interleukin-2 (IL-2) Revenue Forecast by Application (2022-2027) 6.6.3 China Human Interleukin-2 (IL-2) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027 7.2 North America Human Interleukin-2 (IL-2) Market Facts & Figures by Country 7.2.1 North America Human Interleukin-2 (IL-2) Sales by Country (2016-2021) 7.2.2 North America Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Human Interleukin-2 (IL-2) Market Facts & Figures by Region 8.2.1 Asia Pacific Human Interleukin-2 (IL-2) Sales by Region (2016-2021) 8.2.2 Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027 9.2 Europe Human Interleukin-2 (IL-2) Market Facts & Figures by Country 9.2.1 Europe Human Interleukin-2 (IL-2) Sales by Country (2016-2021) 9.2.2 Europe Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027 10.2 Latin America Human Interleukin-2 (IL-2) Market Facts & Figures by Country 10.2.1 Latin America Human Interleukin-2 (IL-2) Sales by Country (2016-2021) 10.2.2 Latin America Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Human Interleukin-2 (IL-2) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Human Interleukin-2 (IL-2) Market Facts & Figures by Country 11.2.1 Middle East and Africa Human Interleukin-2 (IL-2) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Roche 12.1.1 Roche Corporation Information 12.1.2 Roche Description and Business Overview 12.1.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Roche Human Interleukin-2 (IL-2) Products Offered 12.1.5 Roche Recent Development 12.2 BMS 12.2.1 BMS Corporation Information 12.2.2 BMS Description and Business Overview 12.2.3 BMS Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 BMS Human Interleukin-2 (IL-2) Products Offered 12.2.5 BMS Recent Development 12.3 Schering-Plough 12.3.1 Schering-Plough Corporation Information 12.3.2 Schering-Plough Description and Business Overview 12.3.3 Schering-Plough Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Schering-Plough Human Interleukin-2 (IL-2) Products Offered 12.3.5 Schering-Plough Recent Development 12.4 AbbVie Inc 12.4.1 AbbVie Inc Corporation Information 12.4.2 AbbVie Inc Description and Business Overview 12.4.3 AbbVie Inc Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 AbbVie Inc Human Interleukin-2 (IL-2) Products Offered 12.4.5 AbbVie Inc Recent Development 12.5 Alkermes Plc 12.5.1 Alkermes Plc Corporation Information 12.5.2 Alkermes Plc Description and Business Overview 12.5.3 Alkermes Plc Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Alkermes Plc Human Interleukin-2 (IL-2) Products Offered 12.5.5 Alkermes Plc Recent Development 12.6 APT Therapeutics 12.6.1 APT Therapeutics Corporation Information 12.6.2 APT Therapeutics Description and Business Overview 12.6.3 APT Therapeutics Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 APT Therapeutics Human Interleukin-2 (IL-2) Products Offered 12.6.5 APT Therapeutics Recent Development 12.7 Mabtech Limited 12.7.1 Mabtech Limited Corporation Information 12.7.2 Mabtech Limited Description and Business Overview 12.7.3 Mabtech Limited Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Mabtech Limited Human Interleukin-2 (IL-2) Products Offered 12.7.5 Mabtech Limited Recent Development 12.8 Philogen 12.8.1 Philogen Corporation Information 12.8.2 Philogen Description and Business Overview 12.8.3 Philogen Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Philogen Human Interleukin-2 (IL-2) Products Offered 12.8.5 Philogen Recent Development 12.9 Sinopharm 12.9.1 Sinopharm Corporation Information 12.9.2 Sinopharm Description and Business Overview 12.9.3 Sinopharm Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Sinopharm Human Interleukin-2 (IL-2) Products Offered 12.9.5 Sinopharm Recent Development 12.10 Jiangsu Jinsili Pharmaceutical 12.10.1 Jiangsu Jinsili Pharmaceutical Corporation Information 12.10.2 Jiangsu Jinsili Pharmaceutical Description and Business Overview 12.10.3 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Products Offered 12.10.5 Jiangsu Jinsili Pharmaceutical Recent Development 12.11 Roche 12.11.1 Roche Corporation Information 12.11.2 Roche Description and Business Overview 12.11.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Roche Human Interleukin-2 (IL-2) Products Offered 12.11.5 Roche Recent Development 12.12 Beijing Shuanglu Pharmaceutical 12.12.1 Beijing Shuanglu Pharmaceutical Corporation Information 12.12.2 Beijing Shuanglu Pharmaceutical Description and Business Overview 12.12.3 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Beijing Shuanglu Pharmaceutical Products Offered 12.12.5 Beijing Shuanglu Pharmaceutical Recent Development 12.13 Shandong Quangang Pharmaceutical 12.13.1 Shandong Quangang Pharmaceutical Corporation Information 12.13.2 Shandong Quangang Pharmaceutical Description and Business Overview 12.13.3 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Shandong Quangang Pharmaceutical Products Offered 12.13.5 Shandong Quangang Pharmaceutical Recent Development 12.14 Shanghai Huaxin Biological high-tech 12.14.1 Shanghai Huaxin Biological high-tech Corporation Information 12.14.2 Shanghai Huaxin Biological high-tech Description and Business Overview 12.14.3 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Shanghai Huaxin Biological high-tech Products Offered 12.14.5 Shanghai Huaxin Biological high-tech Recent Development 12.15 Beijing Yuance Pharmaceutical 12.15.1 Beijing Yuance Pharmaceutical Corporation Information 12.15.2 Beijing Yuance Pharmaceutical Description and Business Overview 12.15.3 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Beijing Yuance Pharmaceutical Products Offered 12.15.5 Beijing Yuance Pharmaceutical Recent Development 12.16 Beijing Sihuan Biological Pharmaceutical 12.16.1 Beijing Sihuan Biological Pharmaceutical Corporation Information 12.16.2 Beijing Sihuan Biological Pharmaceutical Description and Business Overview 12.16.3 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Beijing Sihuan Biological Pharmaceutical Products Offered 12.16.5 Beijing Sihuan Biological Pharmaceutical Recent Development 12.17 Beijing Sanyuan Gene Pharmaceutical 12.17.1 Beijing Sanyuan Gene Pharmaceutical Corporation Information 12.17.2 Beijing Sanyuan Gene Pharmaceutical Description and Business Overview 12.17.3 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Beijing Sanyuan Gene Pharmaceutical Products Offered 12.17.5 Beijing Sanyuan Gene Pharmaceutical Recent Development 12.18 Shenzhen Kexing Biological Engineering 12.18.1 Shenzhen Kexing Biological Engineering Corporation Information 12.18.2 Shenzhen Kexing Biological Engineering Description and Business Overview 12.18.3 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Shenzhen Kexing Biological Engineering Products Offered 12.18.5 Shenzhen Kexing Biological Engineering Recent Development 12.19 Shanghai Sanwei Biotechnology 12.19.1 Shanghai Sanwei Biotechnology Corporation Information 12.19.2 Shanghai Sanwei Biotechnology Description and Business Overview 12.19.3 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Shanghai Sanwei Biotechnology Products Offered 12.19.5 Shanghai Sanwei Biotechnology Recent Development 12.20 Xiamen Tebao Biological Engineering 12.20.1 Xiamen Tebao Biological Engineering Corporation Information 12.20.2 Xiamen Tebao Biological Engineering Description and Business Overview 12.20.3 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Xiamen Tebao Biological Engineering Products Offered 12.20.5 Xiamen Tebao Biological Engineering Recent Development 12.21 Chengdu huashen Biotechnology 12.21.1 Chengdu huashen Biotechnology Corporation Information 12.21.2 Chengdu huashen Biotechnology Description and Business Overview 12.21.3 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Chengdu huashen Biotechnology Products Offered 12.21.5 Chengdu huashen Biotechnology Recent Development 12.22 Shanghai Pharma Group 12.22.1 Shanghai Pharma Group Corporation Information 12.22.2 Shanghai Pharma Group Description and Business Overview 12.22.3 Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Shanghai Pharma Group Products Offered 12.22.5 Shanghai Pharma Group Recent Development 12.23 Guangdong Xinghao Pharmaceutical 12.23.1 Guangdong Xinghao Pharmaceutical Corporation Information 12.23.2 Guangdong Xinghao Pharmaceutical Description and Business Overview 12.23.3 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Guangdong Xinghao Pharmaceutical Products Offered 12.23.5 Guangdong Xinghao Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Human Interleukin-2 (IL-2) Industry Trends 13.2 Human Interleukin-2 (IL-2) Market Drivers 13.3 Human Interleukin-2 (IL-2) Market Challenges 13.4 Human Interleukin-2 (IL-2) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Human Interleukin-2 (IL-2) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Human Interleukin-2 (IL-2) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 50000 U Table 3. Major Manufacturers of 100000 U Table 4. Major Manufacturers of 200000 U Table 5. Major Manufacturers of 500000 U Table 6. Major Manufacturers of 1 Million U Table 7. Major Manufacturers of 2 Million U Table 8. Global Human Interleukin-2 (IL-2) Market Size Growth Rate by Application (2021-2027) & (KG) Table 9. Global Human Interleukin-2 (IL-2) Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027 Table 10. Global Human Interleukin-2 (IL-2) Sales by Regions (2016-2021) & (KG) Table 11. Global Human Interleukin-2 (IL-2) Sales Market Share by Regions (2016-2021) Table 12. Global Human Interleukin-2 (IL-2) Revenue by Regions (2016-2021) & (US$ Million) Table 13. Global Human Interleukin-2 (IL-2) Sales Forecast by Region (2022-2027) & (KG) Table 14. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Region (2022-2027) Table 15. Global Human Interleukin-2 (IL-2) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 16. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Region (2022-2027) Table 17. Global Human Interleukin-2 (IL-2) Sales by Manufacturers (2016-2021) (KG) Table 18. Global Human Interleukin-2 (IL-2) Sales Share by Manufacturers (2016-2021) Table 19. Ranking of Global Top Human Interleukin-2 (IL-2) Manufacturers by Revenue (US$ Million) in 2020 Table 20. Human Interleukin-2 (IL-2) Revenue by Manufacturers (2016-2021) (US$ Million) Table 21. Human Interleukin-2 (IL-2) Revenue Share by Manufacturers (2016-2021) Table 22. Global Human Interleukin-2 (IL-2) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 23. Global Human Interleukin-2 (IL-2) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Interleukin-2 (IL-2) as of 2020) Table 24. Key Manufacturers Human Interleukin-2 (IL-2) Price (2016-2021) (US$/G) Table 25. Human Interleukin-2 (IL-2) Manufacturers Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Human Interleukin-2 (IL-2) Product Type Table 27. Date of International Manufacturers Enter into Human Interleukin-2 (IL-2) Market Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans Table 29. Global Human Interleukin-2 (IL-2) Sales by Type (2016-2021) (KG) Table 30. Global Human Interleukin-2 (IL-2) Sales Share by Type (2016-2021) Table 31. Global Human Interleukin-2 (IL-2) Revenue by Type (2016-2021) (US$ Million) Table 32. Global Human Interleukin-2 (IL-2) Revenue Share by Type (2016-2021) Table 33. Human Interleukin-2 (IL-2) Average Selling Price (ASP) by Type (2016-2021) & (US$/G) Table 34. Global Human Interleukin-2 (IL-2) Sales Forecast by Type (2022-2027) & (KG) Table 35. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Type (2022-2027) Table 36. Global Human Interleukin-2 (IL-2) Revenue Forecast V (2022-2027) & (US$ Million) Table 37. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Type (2022-2027) Table 38. Global Human Interleukin-2 (IL-2) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/G) Table 39. Global Human Interleukin-2 (IL-2) Sales by Application (2016-2021) (KG) Table 40. Global Human Interleukin-2 (IL-2) Sales Share by Application (2016-2021) Table 41. Global Human Interleukin-2 (IL-2) Revenue by Application (2016-2021) (US$ Million) Table 42. Global Human Interleukin-2 (IL-2) Revenue Share by Application (2016-2021) Table 43. Human Interleukin-2 (IL-2) Average Selling Price (ASP) by Application (2016-2021) & (US$/G) Table 44. Global Human Interleukin-2 (IL-2) Sales Forecast by Application (2022-2027) & (KG) Table 45. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Application (2022-2027) Table 46. Global Human Interleukin-2 (IL-2) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 47. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Application (2022-2027) Table 48. Global Human Interleukin-2 (IL-2) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/G) Table 49. China Human Interleukin-2 (IL-2) Sales (KG) of Key Companies (2016-2021) Table 50. China Human Interleukin-2 (IL-2) Sales Share by Company (2016-2021) Table 51. China Human Interleukin-2 (IL-2) Revenue (US$ Million) by Company (2016-2021) Table 52. China Human Interleukin-2 (IL-2) Revenue Share by Company (2016-2021) Table 53. China Human Interleukin-2 (IL-2) Sales (KG) by Type (2016-2021) Table 54. China Human Interleukin-2 (IL-2) Sales Share by Type (2016-2021) Table 55. China Human Interleukin-2 (IL-2) Revenue (US$ Million) Market Share by Type (2016-2021) Table 56. China Human Interleukin-2 (IL-2) Price (US$/G) by Type (2016-2021) Table 57. China Human Interleukin-2 (IL-2) Sales (KG) by Type (2022-2027) Table 58. China Human Interleukin-2 (IL-2) Sales Share by Type (2022-2027) Table 59. China Human Interleukin-2 (IL-2) Revenue (US$ Million) Market Share by Type (2022-2027) Table 60. China Human Interleukin-2 (IL-2) Revenue Share by Type (2022-2027) Table 61. China Human Interleukin-2 (IL-2) Price (US$/G) by Type (2022-2027) Table 62. China Human Interleukin-2 (IL-2) Sales (KG) by Application (2016-2021) Table 63. China Human Interleukin-2 (IL-2) Sales Share by Application (2016-2021) Table 64. China Human Interleukin-2 (IL-2) Revenue (US$ Million) Market Share by Application (2016-2021) Table 65. China Human Interleukin-2 (IL-2) Price (US$/G) by Application (2016-2021) Table 66. China Human Interleukin-2 (IL-2) Sales (KG) by Application (2022-2027) Table 67. China Human Interleukin-2 (IL-2) Sales Share by Application (2022-2027) Table 68. China Human Interleukin-2 (IL-2) Revenue (US$ Million) Market Share by Application (2022-2027) Table 69. China Human Interleukin-2 (IL-2) Revenue Share by Application (2022-2027) Table 70. China Human Interleukin-2 (IL-2) Price (US$/G) by Application (2022-2027) Table 71. North America Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG) Table 72. North America Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021) Table 73. North America Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million) Table 74. North America Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021) Table 75. Asia Pacific Human Interleukin-2 (IL-2) Sales by Region (2016-2021) & (KG) Table 76. Asia Pacific Human Interleukin-2 (IL-2) Sales Market Share by Region (2016-2021) Table 77. Asia Pacific Human Interleukin-2 (IL-2) Revenue by Region (2016-2021) & (US$ Million) Table 78. Asia Pacific Human Interleukin-2 (IL-2) Revenue Market Share by Region (2016-2021) Table 79. Europe Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG) Table 80. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021) Table 81. Europe Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million) Table 82. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021) Table 83. Latin America Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG) Table 84. Latin America Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021) Table 85. Latin Americaa Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million) Table 86. Latin America Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021) Table 87. Middle East and Africa Human Interleukin-2 (IL-2) Sales by Country (2016-2021) & (KG) Table 88. Middle East and Africa Human Interleukin-2 (IL-2) Sales Market Share by Country (2016-2021) Table 89. Middle East and Africa Human Interleukin-2 (IL-2) Revenue by Country (2016-2021) & (US$ Million) Table 90. Middle East and Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country (2016-2021) Table 91. Roche Corporation Information Table 92. Roche Description and Business Overview Table 93. Roche Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 94. Roche Human Interleukin-2 (IL-2) Product Table 95. Roche Recent Development Table 96. BMS Corporation Information Table 97. BMS Description and Business Overview Table 98. BMS Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 99. BMS Product Table 100. BMS Recent Development Table 101. Schering-Plough Corporation Information Table 102. Schering-Plough Description and Business Overview Table 103. Schering-Plough Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 104. Schering-Plough Product Table 105. Schering-Plough Recent Development Table 106. AbbVie Inc Corporation Information Table 107. AbbVie Inc Description and Business Overview Table 108. AbbVie Inc Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 109. AbbVie Inc Product Table 110. AbbVie Inc Recent Development Table 111. Alkermes Plc Corporation Information Table 112. Alkermes Plc Description and Business Overview Table 113. Alkermes Plc Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 114. Alkermes Plc Product Table 115. Alkermes Plc Recent Development Table 116. APT Therapeutics Corporation Information Table 117. APT Therapeutics Description and Business Overview Table 118. APT Therapeutics Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 119. APT Therapeutics Product Table 120. APT Therapeutics Recent Development Table 121. Mabtech Limited Corporation Information Table 122. Mabtech Limited Description and Business Overview Table 123. Mabtech Limited Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 124. Mabtech Limited Product Table 125. Mabtech Limited Recent Development Table 126. Philogen Corporation Information Table 127. Philogen Description and Business Overview Table 128. Philogen Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 129. Philogen Product Table 130. Philogen Recent Development Table 131. Sinopharm Corporation Information Table 132. Sinopharm Description and Business Overview Table 133. Sinopharm Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 134. Sinopharm Product Table 135. Sinopharm Recent Development Table 136. Jiangsu Jinsili Pharmaceutical Corporation Information Table 137. Jiangsu Jinsili Pharmaceutical Description and Business Overview Table 138. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 139. Jiangsu Jinsili Pharmaceutical Product Table 140. Jiangsu Jinsili Pharmaceutical Recent Development Table 141. Shenyang Sansheng Pharmaceutical Corporation Information Table 142. Shenyang Sansheng Pharmaceutical Description and Business Overview Table 143. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 144. Shenyang Sansheng Pharmaceutical Product Table 145. Shenyang Sansheng Pharmaceutical Recent Development Table 146. Beijing Shuanglu Pharmaceutical Corporation Information Table 147. Beijing Shuanglu Pharmaceutical Description and Business Overview Table 148. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 149. Beijing Shuanglu Pharmaceutical Product Table 150. Beijing Shuanglu Pharmaceutical Recent Development Table 151. Shandong Quangang Pharmaceutical Corporation Information Table 152. Shandong Quangang Pharmaceutical Description and Business Overview Table 153. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 154. Shandong Quangang Pharmaceutical Product Table 155. Shandong Quangang Pharmaceutical Recent Development Table 156. Shanghai Huaxin Biological high-tech Corporation Information Table 157. Shanghai Huaxin Biological high-tech Description and Business Overview Table 158. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 159. Shanghai Huaxin Biological high-tech Product Table 160. Shanghai Huaxin Biological high-tech Recent Development Table 161. Beijing Yuance Pharmaceutical Corporation Information Table 162. Beijing Yuance Pharmaceutical Description and Business Overview Table 163. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 164. Beijing Yuance Pharmaceutical Product Table 165. Beijing Yuance Pharmaceutical Recent Development Table 166. Beijing Sihuan Biological Pharmaceutical Corporation Information Table 167. Beijing Sihuan Biological Pharmaceutical Description and Business Overview Table 168. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 169. Beijing Sihuan Biological Pharmaceutical Product Table 170. Beijing Sihuan Biological Pharmaceutical Recent Development Table 171. Beijing Sanyuan Gene Pharmaceutical Corporation Information Table 172. Beijing Sanyuan Gene Pharmaceutical Description and Business Overview Table 173. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 174. Beijing Sanyuan Gene Pharmaceutical Product Table 175. Beijing Sanyuan Gene Pharmaceutical Recent Development Table 176. Shenzhen Kexing Biological Engineering Corporation Information Table 177. Shenzhen Kexing Biological Engineering Description and Business Overview Table 178. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 179. Shenzhen Kexing Biological Engineering Product Table 180. Shenzhen Kexing Biological Engineering Recent Development Table 181. Shanghai Sanwei Biotechnology Corporation Information Table 182. Shanghai Sanwei Biotechnology Description and Business Overview Table 183. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 184. Shanghai Sanwei Biotechnology Product Table 185. Shanghai Sanwei Biotechnology Recent Development Table 186. Xiamen Tebao Biological Engineering Corporation Information Table 187. Xiamen Tebao Biological Engineering Description and Business Overview Table 188. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 189. Xiamen Tebao Biological Engineering Product Table 190. Xiamen Tebao Biological Engineering Recent Development Table 191. Chengdu huashen Biotechnology Corporation Information Table 192. Chengdu huashen Biotechnology Description and Business Overview Table 193. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 194. Chengdu huashen Biotechnology Product Table 195. Chengdu huashen Biotechnology Recent Development Table 196. Shanghai Pharma Group Corporation Information Table 197. Shanghai Pharma Group Description and Business Overview Table 198. Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 199. Shanghai Pharma Group Product Table 200. Shanghai Pharma Group Recent Development Table 201. Guangdong Xinghao Pharmaceutical Corporation Information Table 202. Guangdong Xinghao Pharmaceutical Description and Business Overview Table 203. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 204. Guangdong Xinghao Pharmaceutical Product Table 205. Guangdong Xinghao Pharmaceutical Recent Development Table 206. Human Interleukin-2 (IL-2) Market Trends Table 207. Human Interleukin-2 (IL-2) Market Drivers Table 208. Human Interleukin-2 (IL-2) Market Challenges Table 209. Human Interleukin-2 (IL-2) Market Restraints Table 210. Human Interleukin-2 (IL-2) Customers List Table 211. Human Interleukin-2 (IL-2) Distributors List Table 212. Research Programs/Design for This Report Table 213. Key Data Information from Secondary Sources Table 214. Key Data Information from Primary Sources List of Figures Figure 1. Human Interleukin-2 (IL-2) Product Picture Figure 2. Global Human Interleukin-2 (IL-2) Sales Market Share by Type in 2020 & 2027 Figure 3. 50000 U Product Picture Figure 4. 100000 U Product Picture Figure 5. 200000 U Product Picture Figure 6. 500000 U Product Picture Figure 7. 1 Million U Product Picture Figure 8. 2 Million U Product Picture Figure 9. Global Human Interleukin-2 (IL-2) Sales Market Share by Application in 2020 & 2027 Figure 10. Recombinant Interferon Figure 11. Recombinant Interleukin Figure 12. Natural Biological Products Figure 13. Poison Immune Figure 14. Gene Therapy Figure 15. Monoclonal Antibody Figure 16. Human Interleukin-2 (IL-2) Report Years Considered Figure 17. Global Human Interleukin-2 (IL-2) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Human Interleukin-2 (IL-2) Market Size 2016-2027 (US$ Million) Figure 19. Global Human Interleukin-2 (IL-2) Sales 2016-2027 (KG) Figure 20. Global Human Interleukin-2 (IL-2) Market Size Market Share by Region: 2021 Versus 2027 Figure 21. Global Human Interleukin-2 (IL-2) Sales Market Share by Region (2016-2021) Figure 22. Global Human Interleukin-2 (IL-2) Sales Market Share by Region in 2020 Figure 23. Global Human Interleukin-2 (IL-2) Revenue Market Share by Region (2016-2021) Figure 24. Global Human Interleukin-2 (IL-2) Revenue Market Share by Region in 2020 Figure 25. Global Human Interleukin-2 (IL-2) Sales Share by Manufacturer in 2020 Figure 26. The Top 10 and 5 Players Market Share by Human Interleukin-2 (IL-2) Revenue in 2020 Figure 27. Human Interleukin-2 (IL-2) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 28. Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2016-2021) Figure 29. Global Human Interleukin-2 (IL-2) Sales Market Share by Type in 2020 Figure 30. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2016-2021) Figure 31. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type in 2020 Figure 32. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2016-2021) Figure 33. Global Human Interleukin-2 (IL-2) Sales Market Share by Application in 2020 Figure 34. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2016-2021) Figure 35. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application in 2020 Figure 36. China Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2027 (KG) Figure 37. China Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2027 (US$ Million) Figure 38. China Human Interleukin-2 (IL-2) Market Share in Global Market 2016-2027 Figure 39. China 5 and 10 Largest Human Interleukin-2 (IL-2) Players Market Share by Revenue in Human Interleukin-2 (IL-2) in 2020 Figure 40. China Human Interleukin-2 (IL-2) Revenue Share by Type (2016-2021) Figure 41. China Human Interleukin-2 (IL-2) Revenue Growth Rate by Type in 2016 & 2020 Figure 42. China Human Interleukin-2 (IL-2) Revenue Share by Application (2016-2021) Figure 43. China Human Interleukin-2 (IL-2) Revenue Growth Rate by Application in 2016 & 2020 Figure 44. North America Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG) Figure 45. North America Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. North America Human Interleukin-2 (IL-2) Sales Market Share by Country in 2020 Figure 47. North America Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2020 Figure 48. U.S. Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 49. U.S. Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Canada Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 51. Canada Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. Europe Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG) Figure 53. Europe Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million) Figure 54. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country in 2020 Figure 55. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2020 Figure 56. Germany Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 57. Germany Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. France Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 59. France Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. U.K. Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 61. U.K. Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Italy Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 63. Italy Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Russia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 65. Russia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Asia Pacific Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG) Figure 67. Asia Pacific Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million) Figure 68. Asia Pacific Human Interleukin-2 (IL-2) Sales Market Share by Region in 2020 Figure 69. Asia Pacific Human Interleukin-2 (IL-2) Revenue Market Share by Region in 2020 Figure 70. China Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 71. China Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Japan Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 73. Japan Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. South Korea Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 75. South Korea Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. India Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 77. India Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Australia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 79. Australia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Taiwan Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 81. Taiwan Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Indonesia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 83. Indonesia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Thailand Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 85. Thailand Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Malaysia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 87. Malaysia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Philippines Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 89. Philippines Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Vietnam Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 91. Vietnam Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Latin America Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG) Figure 93. Latin America Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million) Figure 94. Latin America Human Interleukin-2 (IL-2) Sales Market Share by Country in 2020 Figure 95. Latin America Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2020 Figure 96. Mexico Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 97. Mexico Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 98. Brazil Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 99. Brazil Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Argentina Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 101. Argentina Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Middle East and Africa Human Interleukin-2 (IL-2) Sales Growth Rate 2016-2021 (KG) Figure 103. Middle East and Africa Human Interleukin-2 (IL-2) Revenue Growth Rate 2016-2021 (US$ Million) Figure 104. Middle East and Africa Human Interleukin-2 (IL-2) Sales Market Share by Country in 2020 Figure 105. Middle East and Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2020 Figure 106. Turkey Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 107. Turkey Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 108. Saudi Arabia Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 109. Saudi Arabia Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 110. UAE Human Interleukin-2 (IL-2) Sales Growth Rate (2016-2021) (KG) Figure 111. UAE Human Interleukin-2 (IL-2) Revenue Growth Rate (2016-2021) (US$ Million) Figure 112. Human Interleukin-2 (IL-2) Value Chain Figure 113. Channels of Distribution Figure 114. Distributors Profiles Figure 115. Bottom-up and Top-down Approaches for This Report Figure 116. Data Triangulation Figure 117. Key Executives Interviewed

Roche BMS Schering-Plough AbbVie Inc Alkermes Plc APT Therapeutics Mabtech Limited Philogen Sinopharm Jiangsu Jinsili Pharmaceutical Shenyang Sansheng Pharmaceutical Beijing Shuanglu Pharmaceutical Shandong Quangang Pharmaceutical Shanghai Huaxin Biological high-tech Beijing Yuance Pharmaceutical Beijing Sihuan Biological Pharmaceutical Beijing Sanyuan Gene Pharmaceutical Shenzhen Kexing Biological Engineering Shanghai Sanwei Biotechnology Xiamen Tebao Biological Engineering Chengdu huashen Biotechnology Shanghai Pharma Group Guangdong Xinghao Pharmaceutical